We are proud to announce that BioGnost Ltd. has officially signed a distribution agreement with SLEE Medical GmbH, becoming the exclusive distributor of SLEE products…

Colorectal cancer is one of the most common malignant tumors today. In Croatia, it is the most frequently diagnosed cancer and the second leading cause…

STATEMENTSUBJECT: Replacement for LeukoGnost ALP kit (catalog number LKG-ALP)Dear Sir/Madam,the special LeukoGnost ALP kit (catalog number LKG-ALP), used for enzyme cytochemical staining of fullblood or…

BioGnost is pleased to announce a new partnership with Liquilabo, a French company specializing in the distribution of laboratory reagents, chemicals, and equipment for research…

Two teams, BioGnost Zagreb and BioGnost S Belgrade successfully organized the professional education conference “Green Laboratories – Protocols, Perspectives and New EU Legislative Framework” on…

BioGnost participated in WHX Dubai, a leading international healthcare exhibition that brings together industry professionals from across the globe. The event provided a valuable platform…

We are thrilled to announce that BioGnost will be exhibiting at World Health Expo Labs Dubai 2026, held from 10–13 February 2026 at the Dubai…

Dear partners, and friends, thank you for your trust and successful cooperation throughout the past year.  We continue to invest in innovation and the advancement of…

Wrapping up a successful year with a visit to our sister company BioGnost S in Belgrade – and already gearing up for exciting projects ahead.As…

BioGnost’s internationalization project has been approved to enhance the company’s global competitiveness. We are pleased to announce that funding has been approved for our internationalization…